April 2011

Page 1

April 2011 THE PIONEER NEWSLETTER is brought to you by the students, faculty, and staff of the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. The newsletter staff and its collaborators strive to bring you the latest news from all aspects of the BME community. To submit articles, opinions, ideas, or events for publication and for more information about the newsletter, please visit:

www.thepioneer.gatech.edu

inside this

Issue 4 INVENTURE FINALS BME Wins 5 WORK ABROAD Shresth Shrivastav in Singapore

Volume V, Issue 7

Inventure 2011 BMEs Win at InVenture Prize Finals

T

he third annual Georgia Tech InVenture Prize Finals that took place on March 9, 2011 in the Ferst Center was a tribute to the most innovative and entrepreneurial ideas from this year. The seven finalist teams were chosen by a rigorous judging process over the last six months. Though the ideas presented had undergone enough scrutiny in the previous months to make each of them a viable endeavor, only three could be awarded a prize. a patent. First place ($15,000 and a patent) was awarded to the Slide Capo by Daniel Chaney, second place ($10,000 and a patent) to... Team MAID (Magnetic Assisted Intubation Device) pitches their

Continued on Page 4

innovative intubation method to the judges. (Photo: GTRCI/GIT)

6 GRADUATE SPOTLIGHT Nathan Hotaling

Age of T Cells

7 RESEARCH SERIRES Part III: The Research Option

Researchers Improve Cancer Treatment

By Abby Robinson

M

10 STUDENT SPOTLIGHT Sarah Anderson 11 AMSA PREHEALTH CONFERENCE 11 PREHEALTH COLUMN Extracurriculars 12 AGE OF T CELLS Improving Cancer Treatment 14 FACULTY SPOTLIGHT Dr. Lena Ting 15 DESIGN TOOLBOX Beneficial Tips and Tricks

By Dhruv Vishwakarma

Georgia Tech engineers Catherine Rivet, Abby Hill and Melissa Kemp (left-right) display a diagram of the microfluidic device they used to assess T cells. The drawing illustrates the channels used to measure signaling events. (Credit: Gary Meek)

anipulation of cells by a new microfluidic device may help clinicians improve a promising cancer therapy that harnesses the body's own immune cells to fight diseases such as metastatic melanoma, non-Hodgkin's lymphoma, chronic lymphocytic leukemia and neuroblastoma. The therapy, known as adoptive T cell transfer, has shown encouraging results in clinical trials. This treatment involves removing disease-fighting immune cells called T cells from a cancer patient, multiplying them in the laboratory and then infusing them back into the patient's body to attack the cancer. The effectiveness of this therapy, however, is...

Continued on Page 12


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.